Top 10 Buzzing Stocks Today: Torrent Pharma to Nuvama Wealth Management

Baishakhi Mondal

Published on:

Brokerage Report: Target Prices for 9 Stocks, Suzlon Upgraded to 'Overweight'

Market Overview

On September 27th, the Sensex and Nifty indices are anticipated to open on a positive note. According to early indications from the GIFT Nifty, the Nifty index is likely to start trading with a gain of approximately 54 points. Investors are keen to watch the market closely as various companies are expected to be in focus due to significant news developments.

For Experts Recommendation Join Now

Key Stocks to Watch

CompanyNews
Nuvama Wealth ManagementA major block deal worth Rs 1,464.8 crore involving a 6.4% equity stake is expected. The floor price has been set at Rs 6,455 per share.
RITESSecured a project valued at Rs 87.58 crore from Delhi Metro Rail Corporation, won as part of a consortium. RITES holds a 49% share in the contract, amounting to Rs 42.91 crore.
Torrent PharmaceuticalsDenied allegations regarding its drug Shelcal 500 failing quality tests, asserting the seized sample was counterfeit and not manufactured by them.
Indian BankThe board has approved the raising of additional long-term infrastructure bonds up to Rs 5,000 crore during this financial year.
Piramal EnterprisesIts subsidiary sold real estate assets in Santa Cruz, Mumbai, for Rs 187 crore.
Systematix Corporate ServicesShareholders approved a stock split, dividing one equity share of Rs 10 into ten shares of Rs 1 each at the annual general meeting.
Union Bank of IndiaA proposed strike by a joint platform of customer service associates on September 27 involves approximately 7% of the bank’s workforce.
Railtel Corporation of IndiaSecured a Rs 155.72 crore order from the Maharashtra Rural Development Department for the ASSK-GP project, to be completed by September 2025.
InfosysAnnounced a strategic collaboration with Sally Beauty Holdings Inc. to enhance IT efficiency through hyper-automation.
BioconSigned a licensing and supply agreement with Tabuk Pharmaceutical for commercializing GLP-1 products in select countries in the Middle East.

Conclusion

As traders prepare for the day’s mark shares, these companies are positioned for potential volatility based on their respective news. Investors should stay informed on the latest developments as they could influence trading strategies and market sentiment significantly. Monitoring how these stories unfold can provide valuable insights into market trends and opportunities.

Share This ➥
X